Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd TGF-β for Immuno-Oncology Drug Development Summit

Evvnt Promotion / evvnt
Archivio
-
25.01.2022 - 27.01.2022  Online, USA
Time: 9:00 AM - 5:00 PM
 
Temi della conferenza
From Cell Signaling to the Tumor Microenvironment, Exploit TGF-β’s Role in IO to Harness a Clinically Relevant, Safe & Efficacious Therapeutics

It is clear the world of TGF-β contains vast potential and excitement, in the past year alone we have seen great advances, clinical setbacks, and novel insights into the role of TGF-β.
Professional congress organizer (PCO)
Hanson Wade
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/913463-1?pid=4832
Ms. Erin Thomas
 
Categorie
Oncologia
Lingua
Inglese
Quote del Congresso
USD 599.00 - USD 3598.00
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Anästhesie in Entwicklungsländern e. V.Österreichische Gesellschaft für Public HealthEuropean Public Health Association (EUPHA)Österreichische Akademie der ÄrzteHelix - Forschung & Beratung WienÄrztekammer für WienEuropean Health Forum GasteinSwiss Tropical and Public Health Institute